InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,184.91
(
0.08%
)
US TECH 100
17,608.38
(
-0.01%
)
Dow Jones
38,867.99
(
0.04%
)
Brent Oil
83.18
(
-0.36%
)
Bitcoin
63,211.99
(
0.07%
)
Post# of 42497
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

10nisman

Send PM Follow Ignore
Followers 23
Posts 2525
Boards Moderated 0
Alias Born 10/26/2003

10nisman

Re: Neophius post# 30526

Thursday, 06/24/2021 9:18:48 AM

Thursday, June 24, 2021 9:18:48 AM

Post# of 42497

The main mitigation here is the fact that Humanigen worked closely with the FDA in designing the trials, and have had multiple preliminary meetings prior to application.

Mitigation? Every single company in biotech/pharma space does the exact same thing.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!